Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
31%
OVERLAP
BY WEIGHT
14
# OF OVERLAPPING
HOLDINGS
BBH
26
HOLDINGS
58%
ALSO IN XBI
XBI
116
HOLDINGS
12%
ALSO IN BBH
SECTOR DRIFT (BBH minus XBI)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBH |
Weight in XBI |
Overlap | |
|---|---|---|---|---|
 |
ALNYLAM PHARMACEUTICALS INC | 6.3% | 3.5% | 3.5% |
|
INSMED INC | 4.4% | 3.1% | 3.1% |
|
REGENERON PHARMACEUTICALS | 5.3% | 2.6% | 2.6% |
|
NEUROCRINE BIOSCIENCES INC | 2.8% | 2.5% | 2.5% |
|
GILEAD SCIENCES INC | 12.7% | 2.4% | 2.4% |
BBH Overweight Relative to XBI
|
AMGEN INC | 12.9% |
|
GILEAD SCIENCES INC | 10.3% |
|
VERTEX PHARMACEUTICALS INC | 6.6% |
 |
ARGENX SE ADR | 5.3% |
|
IQVIA HOLDINGS INC | 5.0% |
 |
ICON PLC | 3.6% |
|
BEIGENE LTD. SPONSORED ADR | 3.2% |
|
ILLUMINA INC | 2.9% |
|
ALNYLAM PHARMACEUTICALS INC | 2.8% |
 |
BIONTECH SE SPONSORED ADR | 2.8% |
BBH Underweight Relative to XBI
|
HALOZYME THERAPEUTICS INC | -3.1% |
|
UNITED THERAPEUTICS CORP | -2.6% |
|
ABBVIE INC | -2.5% |
|
MADRIGAL PHARMACEUTICALS, INC. | -2.4% |
|
BRIDGEBIO PHARMA, INC. | -2.3% |
|
EXELIXIS INC | -2.1% |
 |
ROIVANT SCIENCES LTD. | -1.7% |
|
CYTOKINETICS INC | -1.6% |
|
CRISPR THERAPEUTICS AG | -1.5% |
|
IONIS PHARMACEUTICALS, INC. | -1.5% |